Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 3;15(11):e0241323.
doi: 10.1371/journal.pone.0241323. eCollection 2020.

Technical advance: The use of tree shrews as a model of pulmonary fibrosis

Affiliations

Technical advance: The use of tree shrews as a model of pulmonary fibrosis

Jennifer L Larson-Casey et al. PLoS One. .

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease with a high morbidity and mortality. Some of the mechanisms of fibrosis development have been described using rodent models; however, the relevance of findings in these animal models is difficult to assess. New innovative models are needed that closely mimic IPF disease pathology.

Methods: To overcome this unmet need of investigating IPF with a relevant model, we utilized tree shrews, which are genetically, anatomically, and metabolically similar to primates and humans. Using human antibodies and primers, we investigated the role of macrophage phenotypic switching in normal and IPF subjects and bleomycin-injured tree shrews.

Results: Bronchoalveolar lavage (BAL) cells from tree shrews expressed human markers, and there was recruitment of monocyte-derived macrophages (MDMs) to the lung in IPF subjects and bleomycin-injured tree shrews. MDMs were polarized to a profibrotic phenotype in IPF and in bleomycin-injured tree shrews. Resident alveolar macrophages (RAMs) expressed proinflammatory markers regardless of bleomycin exposure. Tree shrews developed bleomycin-induced pulmonary fibrosis with architectural distortion in parenchyma and widespread collagen deposition.

Conclusion: The profibrotic polarization of macrophages has been demonstrated to be present in IPF subjects and in fibrotic mice. Although the lung macrophages have long been considered to be homogeneous, recent evidence indicates that these cells are heterogeneous during multiple chronic lung diseases. Here, we show new data that indicate a critical and essential role for macrophage-fibroblast crosstalk promoting fibroblast differentiation and collagen production. in the development and progression of fibrosis. The current data strongly suggest development of therapeutics that attenuate of the profibrotic activation of MDMs may mitigate macrophage-fibroblast interaction. These observations demonstrate that tree shrews are an ideal animal model to investigate the pathogenesis of IPF as they are genetically, anatomically, and metabolically closer to humans than the more commonly used rodent models.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Recruited monocyte-derived macrophages from tree shrews are increased during fibrosis.
(A) Cell differential of normal (n = 3) and IPF (n = 5) subjects. (B) Representative flow cytometry plots of monocyte-derived macrophages (MDM, CD11b+HLA-DR++CD206++CD169+CD163+) and resident alveolar macrophages (RAM, CD11b+HLA-DR++CD206++CD169+CD163++) of normal (n = 3) and IPF (n = 5) subjects. (C) Total cell number of RAM and MDM from BAL of normal (n = 3) and IPF (n = 5) subjects expressed as fold change. (D) Cell differential of saline- (n = 5) and bleomycin-exposed (n = 4) tree shrews. (E) Representative flow cytometry plots of monocyte-derived macrophages (MDM, CD11b+HLA-DR++CD206++CD169+CD163+) and resident alveolar macrophages (RAM, CD11b+HLA-DR++CD206++CD169+CD163++) of saline- (n = 3) and bleomycin-exposed (n = 3) tree shrews. (F) Total cell number of RAM and MDM from BAL saline- (n = 3) and bleomycin-exposed (n = 3) tree shrews. Representative H & E staining of lung tissue from (G) saline- (n = 6) and (H) bleomycin-exposed (n = 5) tree shews. Masson’s Trichome staining of lung tissue from (I) saline- (n = 6) and (J) bleomycin-exposed (n = 5) tree shews. Scale bar = 100 μm for G-J. (K) Hydroxyproline analysis of saline- (n = 6) and bleomycin-exposed (n = 5) tree shrews. **, p < 0.001; ***, p < 0.0001. Values shown as mean ± S.E.M. Two-way ANOVA with Tukey post-test was utilized for (A), (C), (D), and (F). Two-tailed t-test statistical analysis was utilized for (K).
Fig 2
Fig 2. BAL cells are polarized to a profibrotic phenotype.
(A) Arginase 1, (B) VEGF, (C) CCL18, (D) iNOS, and (E) TNF-α mRNA expression in BAL cells from normal (n = 5–7) or IPF subjects (n = 5–6). BAL cells were isolated and mRNA expression was determined from saline- (n = 6) and bleomycin-exposed (n = 4) tree shrews for (F) arginase 1, (G) VEGF, (H) TGF-β, (I) PDGF-B, (J) iNOS, and (K) TNF-α. *, p < 0.01; ***, p < 0.0001. Values shown as mean ± S.E.M. Two-tailed t-test statistical analysis was utilized.
Fig 3
Fig 3. Recruited monocyte-derived macrophages are polarized to a profibrotic phenotype.
Tree shrews were exposed to saline (n = 3) or bleomycin (n = 3) and BAL cells were isolated. FACS-sorted RAMs and MDMs were analyzed for (A) arginase 1, (B) VEGF, (C) TGF-β, (D) PDGF-B, (E) iNOS, and (F) TNF-α mRNA expression. ***, p < 0.0001. Values shown as mean ± S.E.M. One-way ANOVA with Tukey post-test was utilized.
Fig 4
Fig 4. Macrophage-derived profibrotic gene expression regulates fibroblast differentiation.
(A) Immunoblot analysis of IPF fibroblasts cultured in BAL fluid from saline- (n = 3) or bleomycin-exposed (n = 3) tree shrews. (B) Quantification of α-SMA expression in A (n = 3 per group). mRNA analysis of (C) collagen 1a and (D) fibronectin in IPF fibroblasts cultured in BAL fluid from saline- (n = 3) or bleomycin-exposed (n = 3) tree shrews. **, p < 0.001; ***, p < 0.0001. Values shown as mean ± S.E.M. Two-tailed t-test statistical analysis was utilized.

Similar articles

Cited by

References

    1. Collard HR, Ward AJ, Lanes S, Cortney Hayflinger D, Rosenberg DM, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ. 2012;15(5):829–35. Epub 2012/03/30. 10.3111/13696998.2012.680553 . - DOI - PubMed
    1. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(7):810–6. Epub 2006/07/01. 10.1164/rccm.200602-163OC . - DOI - PubMed
    1. Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med. 2014;2(7):566–72. 10.1016/S2213-2600(14)70101-8 . - DOI - PubMed
    1. Burman A, Kropski JA, Calvi CL, Serezani AP, Pascoalino BD, Han W, et al. Localized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous protein. JCI Insight. 2018;3(16). Epub 2018/08/24. 10.1172/jci.insight.99543 - DOI - PMC - PubMed
    1. Larson-Casey JL, Vaid M, Gu L, He C, Cai GQ, Ding Q, et al. Increased flux through the mevalonate pathway mediates fibrotic repair without injury. J Clin Invest. 2019;129(11):4962–78. Epub 2019/10/15. 10.1172/JCI127959 - DOI - PMC - PubMed

Publication types

MeSH terms